EXHIBIT 4.5

                                 EUPHONIX, INC.
                      AMENDMENT TO SECURED PROMISSORY NOTE
                             DATED SEPTEMBER 7, 2000

       This agreement dated November 29, 2001 (the "Amendment") amends the
Secured Promissory Note (the "Note"), dated September 7, 2000 between Euphonix,
Inc., a California corporation ("Borrower") and Walter Bosch (the "Investor" or
"Lender") as amended up to the date of this Amendment. This Amendment will
become effective immediately prior to the date of the Secured Promissory Note to
be executed (the "Execution Date") in connection with the Financing (as defined
below). Capitalized terms not defined here have the meaning set forth in the
Note.

                                    RECITALS

       A. The Borrower has arranged for a debt financing of up to $6 million
(the "Financing") that is contingent on the Investor agreeing to amend the Note
to among other things, extend the maturity date in exchange for increasing the
number of shares issuable to Investors upon conversion of the Note and the
waiver by Dieter Meier and Walter Bosch of any claims of Borrower's alleged
default under notes payable by Borrower to Messrs. Meier and Bosch.

       B. Subsection G.6 of the Note provides that the Note may be amended by a
written instrument signed by Borrower and the Lender.

       NOW, THEREFORE, in consideration of the mutual promises set forth herein,
and for other good and valuable consideration (including that recited in
Paragraph A, above), the receipt and sufficiency of which is hereby
acknowledged, the parties agree as follows:

                              ARTICLE I: AMENDMENTS

       1. Subsection B.1 of the Note is hereby amended by replacing it in its
entirety by the following new subsection:

       "Scheduled Payment. Subject to other provisions of this Note, the
       outstanding principal sum of this Note, together with the accrued
       interest thereon, shall be due and payable on December 31, 2003."

       2. Subsection B.5(a)(ii) of the Note is hereby amended by replacing it in
its entirety by the following new provision:

       "(ii) the lower of: (A) $0.35 or (B) the average of the closing price per
       share for the 3 trading days immediately preceding the Execution Date,
       provided, however that the price per share as determined in this clause
       (B) can be no lower than $0.02 per share."

       3. Subsection B.5(c) of the Note is hereby amended by replacing it in its
entirety by the following new provision:




       "Notwithstanding anything herein to the contrary, unless waived by the
       holders of a majority of the outstanding principal amount of this Note,
       the outstanding principal sum from all Advances as of the date thereof
       and all accrued interest thereon, shall accelerate and become due and
       payable in full, according to each Investor's Pro Rata Share upon the
       occurrence of any of the following (each, a "Transaction"): (i) the sale,
       transfer or other disposition of any of Borrower's material assets (not
       including product inventory for sale to customers in the ordinary course
       of business), (ii) the acquisition of voting control in excess of 50% of
       Borrower by persons (other than the Investors), or (iii) the merger or
       consolidation of Borrower with or into another entity whereby the holders
       of Borrower's voting securities prior to such merger or consolidation
       hold less than 50% of the voting securities of the surviving entity.
       Notice of any such Transaction shall be provided to the Investors
       fourteen (14) calendar days prior to the consummation of any such
       Transaction and, notwithstanding anything to the contrary contained
       elsewhere in this Note, Investors may exercise their rights of conversion
       during such 14-day period."

       4. The Note is hereby amended by adding in the following new provision as
new Subsection B.5(d):

       "Notwithstanding anything herein to the contrary, this Note shall not be
       convertible into shares of Common Stock as contemplated herein, until
       such time as the Borrower has obtained shareholder approval of (i) an
       amendment to the Company's Articles of Incorporation to authorize a
       sufficient number of additional shares of Common Stock for potential
       issuance upon conversion of this Note, and (ii) this Amendment. Borrower
       hereby covenants that it will hold a meeting of its shareholders, or
       otherwise seek written consents of its shareholders, as soon as
       practicable after the date of this Amendment in order to seek such
       shareholder approval. The Investors further acknowledge that: (i)
       Borrower will authorize, in its Articles of Incorporation, a total of 150
       million shares of Common Stock, of which 125 million will be reserved for
       issuance upon: (x) conversion of this Note, (y) conversion of the
       convertible promissory notes dated February 22, 2000, April 14, 2000,
       December 29, 2000, March 15, 2001, and November 29, 2001, and (z)
       exercise of warrants issued pursuant to Section G.1 of the convertible
       promissory note dated November 29, 2001; and that (ii) the Investors
       cannot effect any such conversion or exercise as described in the
       foregoing clause (i) that exceeds 125 million shares unless and until the
       shareholders approve an amendment to the Articles of Incorporation
       increasing the number of authorized shares to an amount that permits such
       exercise or conversion."

       5. Subsection F.2 of the Note is hereby deleted in its entirety.

       6. Subsection G.6 of the Note is hereby amended by replacing it in its
entirety by the following new provision:

       "AMENDMENT PROVISIONS. This Note may be amended by the addition or
       deletion of any provisions thereof and any rights of a Lender may be
       modified in writing by the Borrower and Lenders holding this and similar
       notes from the Borrower originally issued on February 22, 2000, April 14,
       2000, September 7, 2000, December 29, 2000 and March 15, 2001 in any
       manner; provided, however, that no such amendment shall, without the
       consent of each


                                      -2-


       Lender to be affected thereby: (i) extend the Scheduled Payment date set
       forth in Subsection C.1, (ii) reduce the principal amount of the Note,
       (iii) decrease any interest rate payable under the Note, (iv) change the
       currency in which the Note is payable, (v) impair any rights of a holder
       against the Borrower upon any Event of Default, (vi) modify any of the
       conversion features of the Notes or increase the amounts set forth in
       Subsection B.5(a)(ii), or (vii) impair any Lenders' lien on the
       Borrower's assets."

       7. A new Subsection G.12 is hereby added to the Note that states in its
entirety as follows:

       "Intercreditor Agreement. This Note is subject to the terms and
       conditions of an Intercreditor Agreement, dated as of November 29, 2001
       (the "Intercreditor Agreement"), among Borrower, the Investors and
       certain other holders of Secured Promissory Notes issued by Borrower. In
       the event of any conflict between the provisions of Section 1 of the
       Intercreditor Agreement and any provision of this Note, the provision of
       such Section 1 shall govern and control."

                               ARTICLE II: GENERAL

       1. Governing Law; Venue. This Amendment shall be governed by the laws of
the State of California, without giving effect to conflicts of law principles.
Borrower and Lender agree that all actions or proceedings arising in connection
with this Amendment shall be tried and litigated only in the state and federal
courts located in the City and County of Santa Clara, State of California or, at
Lender's option, any court in which Lender determines it is necessary or
appropriate to initiate legal or equitable proceedings in order to exercise,
preserve, protect or defend any of its rights and remedies under this Amendment
or otherwise or to exercise, preserve, protect or defend its Lien, and the
priority thereof, against the Collateral, and which has subject matter
jurisdiction over the matter in controversy.

       2. Entire Agreement; Counterparts. This Amendment and the Note together
embody the entire understanding and agreement between Borrower and the Investors
and supersede all prior agreements and understandings relating to the subject
matter hereof. This Amendment may be executed in any number of counterparts,
each of which shall be enforceable against the parties actually executing such
counterparts, and all of which together shall constitute one instrument.

       3. Security Interest. Borrower acknowledges that it has granted to the
Investors a security interest in the Collateral to secure the payment of all of
the Secured Obligations including, without limitation, principal, accrued
interest, other advances made under the Note and any attorneys' fees to which
the Investors are entitled under the Note. Borrower acknowledges that it has
taken prior to the date hereof all actions required and reasonably necessary to
perfect and to otherwise give notice of the security interest granted hereunder
including, but not limited to, the execution and filing of financing statements
and the filing of notices of security interests with the United States Patent
and Trademark Office.


                                      -3-


       4. Restrictions on Transfer and Compliance with Securities Act; Investor
Representations and Warranties.

              (a) Certificates representing any of the shares of Common Stock
acquired pursuant to the provisions of this Note shall have endorsed thereon the
following legends, as appropriate.

                     (i) Such shares of Common Stock will not be registered
under the Securities Act of 1933, as amended (the "Securities Act"), nor
qualified (if necessary) under applicable state securities laws and consequently
will have the following legend:

       "THE SECURITIES EVIDENCED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED
       UNDER THE SECURITIES ACT OF 1933, AS AMENDED, AND MAY NOT BE SOLD,
       TRANSFERRED, ASSIGNED OR HYPOTHECATED UNLESS THERE IS AN EFFECTIVE
       REGISTRATION STATEMENT UNDER SUCH ACT COVERING SUCH SECURITIES, THE SALE
       IS MADE IN ACCORDANCE WITH RULE 144 UNDER THE ACT, OR THE COMPANY
       RECEIVES AN OPINION OF COUNSEL FOR THE HOLDER OF THESE SECURITIES
       REASONABLY SATISFACTORY TO THE COMPANY, STATING THAT SUCH SALE, TRANSFER,
       ASSIGNMENT OR HYPOTHECATION IS EXEMPT FROM THE REGISTRATION AND
       PROSPECTUS DELIVERY REQUIREMENTS OF SUCH ACT."

                     (ii) Any legend required to be placed thereon by any
applicable state securities laws.

              (b) Each Investor, by acceptance hereof or by making any Advances,
agrees that the Note, as amended by this Amendment, and the shares of Common
Stock to be issued upon conversion pursuant to the terms of the Note, as amended
by this Amendment, are being acquired solely for his own account and not as a
nominee for any other party and not with a view toward the resale or
distribution thereof and that he will not offer, sell or otherwise dispose of
the Note, as amended by this Amendment, or any shares of Common Stock to be
issued upon conversion pursuant to the terms hereof except under circumstances
which will not result in a violation of the Securities Act or of applicable
state securities laws.

              (c) Each Investor, by acceptance hereof, represents that such
Investor is (i) an accredited investor within the meaning of Rule 501 under the
Securities Act and has such knowledge and experience in financial and business
matters that he is capable of evaluating the merits and risks of the purchase of
the Note, as amended by this Amendment, and can bear the economic risk of his
investment; (ii) aware of the Borrower's business affairs and financial
condition; and (iii) aware that the Note, as amended by this Amendment, has not
been registered under the Securities Act in reliance upon a specific exemption
therefrom.


                                      -4-


              (d) Subject to the preceding, the Note, as amended by this
Amendment, may be transferred only upon surrender of the original Note as
amended by this Amendment, for registration of transfer, duly endorsed, or
accompanied by a duly executed written instrument of transfer in form
satisfactory to Borrower. Thereupon, a new note for like principal amount and
interest will be issued to, and registered in the name of, the transferee.
Interest and principal are payable only to the Investors or their transferees
set forth on Exhibit A to the Note.

                [remainder of the page intentionally left blank]


                                      -5-


       IN WITNESS WHEREOF, the Borrower and each of the Investors has caused
this Note to be duly executed on the date first written above.


                                        EUPHONIX, INC.


                                        By: /s/ Jeffrey Chew
                                            ------------------------------------
                                        Name: Jeffrey Chew
                                        Title: Chief Executive Officer


                                        INVESTOR


                                        /s/ Walter Bosch
                                        ----------------------------------------
                                        Walter Bosch


[SIGNATURE PAGE TO AMENDMENT TO SECURED PROMISSORY NOTE DATED SEPTEMBER 7, 2000]